$64.99
Description
Saypha® Volume with Lidocaine is a hyaluronic acid based dermal filler used to add volume to the skin. The addition of lidocaine, a local anesthetic, helps to minimize discomfort during the injection process.
Composition:
• Hyaluronic acid (23 mg/ml)
• Lidocaine (0.3%)
Side effects:
• Mild irritation
• Swelling
• Redness
• Bruising at the injection site
Packaging:
• 1 pre-filled syringe of 1ml
• 2 needles 27G 1/2
Specifications
- Main Ingredient: Hyaluronic Acid
- Manufacturer: Croma Pharma
- Drug Class: Aesthetic Surgery Product
- Generic Name: Cross-Linked Hyaluronic Acid
- Package Contents: 1mL x 1 Pre-Filled Syringe
- Storage Requirements: Room Temperature (2℃~25℃)
- Main Usage:
About the Brand
Saypha
Here to help
Questions about ordering, delivery or products? You can email our team here or call now at 1-800-630-9757 and be connected with your dedicated Account Manager
Related Products
Intraline PDO Thread M2738 – Mono
Intraline® B 2390-C
Hyafilia® Petit Plus with Lidocaine
Related Articles
Juvederm Before and After: Visible Results, Lasting Impact
In today’s aesthetic market, results-driven visuals are more than just impressive—they’re essential. For aesthetic clinics…
How RADIESSE® Boosts Collagen for Long-Lasting Results
As the demand for non-surgical facial rejuvenation grows, medical practitioners seek effective, long-lasting solutions to…
The Science Behind Jalupro: How It Stimulates Collagen Production
Collagen is essential for maintaining youthful and healthy skin, but its natural production decreases as…
AESTHEFILL Injection: Skin Collagen Stimulators
Collagen stimulators like Aesthefill are redefining how we approach skin rejuvenation. Unlike traditional fillers that…
Collagen vs Hyaluronic Acid: Choosing the Best for Wrinkle Reduction
Choosing between collagen vs hyaluronic acid fillers is crucial in aesthetic medicine, particularly for wrinkle…
Sculptra Aesthetic: Stimulating Collagen for Youthful Skin
In the ever-evolving world of cosmetic treatments, Sculptra Aesthetic stands out as a revolutionary option…